We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following a scientific forum hosted by KSU, the collective data presented on non-hereditary DCM points to neither a cause nor an increase in the number of occurrences.
The market research firm has highlighted opportunities for cat product proliferation, ingredient and sourcing claims, private label brand growth and other opportune areas for the industry to grow.
A peer-reviewed article from a team of veterinary professionals and nutritionists with BSM Partners determined more comprehensive research that considers several confounding factors is needed.
Several of the 16 brands called out in the FDA’s recent report have responded to the confusion, concern and, in some cases, blame among some pet owners.
As the FDA continues to investigate cases of DCM, pet food formulators try to determine what, if any, implications the investigation has on ingredient categories.